Sun protection product developer Nanosive has been launched by Truffle Capital with a licence from Yale University.
Nanosive, the France-based developer of a sun protection product based partly on Yale University research, obtained an undisclosed amount of funding yesterday from venture capital firm Truffle Capital’s BioMedTech Fund.
Nanosive was incorporated by Truffle in December 2017 and has secured a licence for Yale technology which uses active nanoparticles drawn from polymers to offer better UV protection from the sun, helping to prevent skin cancer and slow the effects of ageing.
The Yale research was led by Mark Saltzman, professor of biomedical engineering, chemical and environmental engineering, and physiology, along with Michael Girardi, vice-chairman of the university’s dermatology department.
Saltzman and Girardi are both acknowledged as scientific co-founders of the company, which operates from the newly-launched Obratori incubator run by beauty product manufacturer L’Occitane.
John Puziss, director of business development in Yale’s Office of Cooperative Research, said: “We are delighted to partner with Truffle Capital…
